Corline Biomedical AB (CLBIO) — Tangible Net Worth Ratio
Corline Biomedical AB (CLBIO) has a Tangible Net Worth Ratio of 25.9% as of March 2026. This metric is calculated by deducting intangible assets (Skr74.45 Million) from net assets (Skr100.45 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore CLBIO net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Corline Biomedical AB Tangible Net Worth Ratio (2012–2025)
This chart shows how Corline Biomedical AB's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 25.9%, reflecting net assets of Skr100.45 Million with intangible assets of Skr74.45 Million SEK. For live market cap and overall valuation, see market value of Corline Biomedical AB.
Annual Tangible Net Worth Ratio for Corline Biomedical AB (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Corline Biomedical AB from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore CLBIO capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 20.6% | Skr93.76 Million | Skr74.43 Million | Skr98.58 Million | ▲ +5.2 pp |
| 2024 | 15.4% | Skr86.91 Million | Skr73.50 Million | Skr94.76 Million | ▼ -3.1 pp |
| 2023 | 18.6% | Skr93.32 Million | Skr75.99 Million | Skr100.11 Million | ▼ -12.2 pp |
| 2022 | 30.7% | Skr94.59 Million | Skr65.50 Million | Skr101.78 Million | ▼ -7.8 pp |
| 2021 | 38.6% | Skr92.23 Million | Skr56.66 Million | Skr101.66 Million | ▲ +29.8 pp |
| 2020 | 8.8% | Skr52.03 Million | Skr47.47 Million | Skr58.28 Million | ▼ -26.0 pp |
| 2019 | 34.7% | Skr59.32 Million | Skr38.72 Million | Skr63.75 Million | ▼ -3.6 pp |
| 2018 | 38.4% | Skr54.96 Million | Skr33.88 Million | Skr62.91 Million | ▲ +10.2 pp |
| 2017 | 28.2% | Skr45.93 Million | Skr32.98 Million | Skr51.43 Million | ▲ +0.4 pp |
| 2016 | 27.8% | Skr38.75 Million | Skr27.96 Million | Skr41.27 Million | ▼ -68.9 pp |
| 2015 | 96.7% | Skr21.25 Million | Skr695.97K | Skr24.99 Million | ▲ +6.1 pp |
| 2014 | 90.6% | Skr5.48 Million | Skr512.99K | Skr16.77 Million | ▼ -9.4 pp |
| 2013 | 100.0% | Skr8.00 Million | Skr0.00 | Skr13.76 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Skr1.37 Million | Skr0.00 | Skr12.46 Million | — |